Rezultati - Torsten Zimmermann

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial

    The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial od Antonia M. Joussen, Sebastián Wolf, Peter K. Kaiser, David S. Boyer, Thomas Schmelter, Rupert Sandbrink, Oliver Zeitz, Gesa Deeg, Annett Richter, Torsten Zimmermann, Joachim Hoechel, Ulf Buetehorn, Walter Schmitt, Brigitte Stemper, Michael Karl Boettger

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106

    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106 od Akihiro Takano, Fredrik Piehl, Jan Hillert, Andrea Varrone, Sangram Nag, Balázs Gulyás, Per Stenkrona, Victor L. Villemagne, Christopher C. Rowe, Richard Macdonell, Nabil Al Tawil, Thomas Kucinski, Torsten Zimmermann, Marcus Schultze‐Mosgau, Andrea Thiele, Anja Hoffmann, Christer Halldin

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: